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Objective: to evaluate leukocyte rheology, polymorphonuclear leukocyte (PMN) membrane fluidity and cytosolic Ca2+
concentration in subjects with post-phlebitic leg syndrome (PPS) and acute deep-venous leg thrombosis (DVT).
Subjects: twenty-two subjects with leg PPS and 14 subjects with leg DVT.
Methods: we evaluated the leukocyte filtration (unfractionated, mononuclear cells (MN) and PMN), the PMN membrane
fluidity and the PMN cytosolic Ca2+ concentration. Subsequently, we evaluated the same PMN variables after in vitro
chemotactic activation with 4-phorbol 12-myristate 13-acetate (PMA) and N-formyl-methionyl-leucyl-phenylalanine
(fMLP).
Results: at baseline we observed a significant difference in the filtration variables of unfractionated and MN cells and
in PMN cytosolic Ca2+ concentration. After activation, in normal subjects and subjects with PPS and DVT, a significant
variation in PMN filtration at 5 and 15 minutes was evident. In normal subjects, no variation was present in PMN
membrane fluidity or cytosolic Ca2+ concentration after activation. In subjects with PPS and DVT, we found a decrease
in PMN membrane fluidity and an increase in PMN cytosolic Ca2+ concentration. After PMN activation (at 5 and
15 min) D% of IRFR distinguished normal subjects from subjects with PPS and DVT, while no difference was found in
D% of membrane fluidity or cytosolic Ca2+ concentration.
Conclusions: there is a functional alteration of leukocytes in these patients whose mechanisms are not yet clear.
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Introduction or to the generation of a range of cytokines (IL-8, IL-
1, etc.) which are sufficient to activate the PMNs, with
There are several reports regarding the role of the release of free radicals and proteolytic enzymes5,7,8,10
leukocytes in venous disease including varicose veins, that aggravates the local tissue damage.
chronic venous insufficiency and deep-venous throm- The granulocyte activation, that in normal subjects
bosis (DVT).1–12 Almost all these clinical conditions can be caused during acute experimental venous
are characterised by chronic venous hypertension. In hypertension, has been shown to be due to an increase
chronic venous hypertension, prolonged standing in the lactoferrin level.7 An increase in the elastase
causes greater trapping of leukocytes in the micro- plasma level has been found also in subjects with
circulatory bed of the foot than normal subjects.4 venous diseases, although this increase was not related
However, the role played by the leukocytes in the to the granulocyte count.8 On the other hand, other
microvasculature of the subjects with chronic venous authors11 have demonstrated that granulocytes of
hypertension is differentiated, as trapping involves limbs with chronic venous disease produce, after
especially monocytes (MN) while the activation in- stimulation with fMLP, more oxygen free radicals,
volves only the granulocytes (PMN).13 These two expressed as a ratio of leg-to-arm luminescence. The
events contribute to the skin trophic damage even- same authors11 found a significant reduction of fMLP
tually leading to ulceration. MN trapping leads either receptors on activated leg granulocytes in comparison
to a microcirculatory-flow decrease with local hypoxia with the fMLP receptors of those isolated from arms.
The aim of this research was to examine the leuko-
cyte-flow properties, the PMN membrane fluidity and* Please address all correspondence to: G. Caimi, Via Leonardo da
Vinci 52, I-90145 Palermo, Italy. cytosolic Ca2+ concentration in a group of subjects
1078–5884/99/110411+06 $12.00/0 Ó 1999 Harcourt Publishers Ltd.
G. Caimi et al.412
with PPS and in a group of subjects with DVT, before nominal pore size of 8 lm (Nucleopore) were used, and
the pressure head was-3 cm H2O) for unfractionatedand after in vitro chemotactic activation.
leukocytes and MN cells, -4 cm H2O for PMN cells.
The variables considered were the initial relative flow
rate (IRFR), relative to the buffer solution, and the
Subjects concentration of clogging particles (CP).
Thirty-six patients were enrolled in this study. Twenty-
two subjects (14 M, 8 F; mean age 59.6, s.d. 15.0 years)
were affected by post-phlebitic leg syndrome (PPS)
while 14 subjects (6 M, 8 W; mean age 49.3, s.d.
PMN membrane fluidity16.7 years) were affected by acute deep-venous leg
thrombosis (DVT). All these patients had undergone
PMNs were suspended in Dulbecco’s buffer at a con-clinical examination, Doppler and echo-colour-Dop-
centration of 4·106 cells/ml, and labelled with 1-pler velocimetry. All PPS subjects had moderate
[4-(trimethylamino)phenyl]-6-phenyl-1,3,5-hexatrienechronic venous insufficiency (stage 2), characterised
(TMA-DPH-Molecular Probes, Junction City, OR,by non-ulcerating skin changes.14 No subject in this
U.S.A.), previously dissolved in acetone. The labellinggroup had suffered from acute venous thrombosis in
was effected as follows: 4 min pre-incubation at 4 °Cthe two years preceding the study. In each patient the
followed by incubation for 20 min at 37 °C, with aposterior tibial-vein pressure in the standing position
final probe concentration of 2 lM. Fluorescence(measured by echo-colour Doppler according to the
measurement was effected at 37 °C, using a spectro-Gaylis method15) was at least 90 mmHg. All DVT
photofluorimeter (Mod. LS5, Perkin-Elmer, Beacons-subjects were examined within 3 days from the onset
field, U.K.) equipped with polarisation accessories. Theof clinical symptoms. None of the subjects included
excitation wavelength was 360 nm and the emissionin this study were affected by impaired glucose tol-
wavelength was 430 nm. Examining the fluorescenceerance or non-insulin-dependent diabetes mellitus or
intensity with the polarisers oriented parallel and per-dyslipidaemia. No patient had undergone treatment
pendicular to the plane of polarisation, we calculatedwith drugs which might have interfered with leukocyte
the fluorescence polarisation degree (p), inversely re-function.
lated to PMN membrane lipid fluidity.19–21
Methods
Venous blood samples were drawn from arms of
PMN cytosolic Ca2+ contentfasting patients and anticoagulated with ethylene-
diaminetetra-acetate (EDTA)-K3 (1.5 mg/ml). An un-
PMNs were suspended in Dulbecco’s buffer at a con-fractionated leukocyte suspension was prepared
centration of 2·106 cells/ml and marked with theaccording to the method described by Mikita et al.16
fluorescent probe Fura 2-AM (Molecular Probes), pre-In the final preparation leukocytes were suspended
viously dissolved in dimethylsulphoxide (DMSO). Thein Dulbecco’s phosphate-buffered saline containing
labelling was effected as follows: 4 min pre-incubationEDTA-K3 (1 mg/ml). Leukocytes were separated into
at 4 °C followed by incubation for 30 min at 37 °C,MN and PMN cells,17 using a Ficoll–Hypaque medium
with a final probe concentration of 1.0 lM, and a finalwith a density of 1.114 g/ml (Mono-Poly Resolving
DMSO concentration of 0.5%. This procedure isMedium, Flow Laboratories Ltd, Irvin, U.K.).
considered sufficient to inhibit Fura 2-AM uptake
in endocytic vesicles.22 Fluorescence measurement
was effected using the Perkin-Elmer LS5 spectro-
photofluorimeter. The excitation wavelength wasWBC filtration
335 nm for the Fura 2-Ca2+ complex and 385 nm for
the unchelated Fura 2, while the emission wavelengthUnfractionated, MN and PMN suspensions were
adjusted to a cell count of 3·106 cells/ml. The filtration was 505 nm. In agreement with Roe et al.22 and David-
Dufilho et al.,23 we considered the ratio between thewas performed using a St. George’s Filtrometer (Carri-
Med, Dorking, U.K.).18 Each cell suspension was tested Fura 2-Ca2+ complex and the fluorescence intensity of
the unchelated Fura 2 (335 nm/385 nm).against its cell-free suspension medium. Filters with a
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PMN activation 2–3). There was no significant difference in PMN mem-
brane fluidity between normal subjects and subjects
The PMN variables (filtration, membrane fluidity and with PPS or DVT, whereas both groups of patients
showed a significant increase in PMN cytosolic Ca2+Ca2+ calcium concentration) were evaluated, according
to the methods described above, after activation with concentration (Tables 2–3).
After PMN activation with PMA (Table 2), a sig-chemotactic agents. After separation, a portion of PMN
cells were subdivided into several aliquots, each of nificant decrease in IRFR and significant increase in
CP were observed in normal and all other patients. Nowhich, having a concentration of 5·106 cells/ml, was
treated with two activating agents: 4-phorbol 12-myr- significant variation was present in PMN membrane
fluidity or PMN cytosolic Ca2+ concentration in normalistate 13-acetate (PMA, Sigma Chemical) and N-for-
myl-methionyl-leucyl-phenylalanine (fMLP, Sigma patients, whereas in subjects with PPS and DVT a
decrease in PMN membrane fluidity and an increaseChemical). The activation was carried out in vitro, in
accordance with the methods described by Yasui et in PMN cytosolic Ca2+ concentration were observed.
After PMN activation with fMLP (Table 3), a sig-al.24 and Masuda et al.,25 as follows: the fractions of PMN
suspension were treated, in separate experiments, with nificant decrease in IRFR and significant increase in
CP were found in normal subjects and in subjects with4.5 lM of PMA or with 10-5 m of fMLP, and incubated
for 5 min at 37 °C; additional PMN suspensions, sub- PPS and DVT. No significant variation was present
in PMN membrane fluidity or PMN cytosolic Ca2+mitted to the same treatment, were incubated for
15 min at 37 °C. At the end of incubation the activation concentration in normal subjects. In subjects with PPS
a significant decrease in PMN membrane fluidity andwas stopped by plunging the tubes into melting ice
for a few minutes and, soon after, the PMN suspensions a significant increase in PMN cytosolic Ca2+ con-
centration was observed. In subjects with DVT nowere centrifuged at 200 g for 10 min at 20 °C, and
resuspended in 1 ml of Dulbecco’s buffer containing significant variation was present in PMN membrane
fluidity, while a late and slight increase in PMN cy-EDTA-K3 (1 mg/ml).
The same variables were evaluated in a group of 34 tosolic Ca2+ concentration was found.
After PMN activation with PMA, in comparison withnormal subjects (25 M, 9 F; mean age 40.7, s.d. 8.6
years). basal values, D% of IRFR was significantly different
between normal subjects, subjects with PPS and sub-
jects with DVT at 5 min (n=-39.3, s.d. 24.7, PPS=
-67.2, s.d. 21.2, DVT=-70.2, s.d. 24.2, F=6.87,
Statistical analysis p<0.001) and at 15 min (n=-38.4, s.d. 25.8, PPS=
-62.7, s.d. 24.8, DVT=-84.3, s.d. 8.7, F=15.28,
The results were expressed as means and standard p<0.01). At neither point in time were the D% of PMN
deviations (s.d.). The mean difference between normal membrane fluidity and cytosolic Ca2+ concentration
subjects, PPS and DVT subjects was evaluated ac- different between the three groups.
cording to Student’s t-test for unpaired data. The After PMN activation with fMLP, in comparison
difference between the means of all PMN variables at with basal values, D% of IRFR was significantly dif-
baseline and after activation was investigated ac- ferent between normal subjects, subjects with PPS and
cording to Student’s t-test for paired data. A one-way subjects with DVT at 5 min (n=-13.6, s.d. 12.5, PPS=
ANOVA model was used to evaluate, during activation -20.9, s.d. 27.6, DVT=-39.3, s.d. 19.0, F=4.97,
with PMA and fMLP, the difference between means p<0.05) and at 15 min (n=-6.9, s.d. 9.1, PPS=-36.1,
of variations (D%) in normal subjects, in subjects with s.d. 25.2, DVT=-52.4, s.d. 23.1, F=17.25, p<0.001). At
PPS and in subjects with DVT. neither point in time were the D% of PMN membrane
fluidity and cytosolic Ca2+ concentration different be-
tween the three groups.
Results
At baseline there was a significant difference in the Discussion
unfractionated and MN’s filtrability between normal
subjects and subjects with PPS or DVT (Table 1). PPS At baseline, the leukocyte filtration variables (IRFR
and CP) were different in subjects with PPS and DVTand DVT subjects showed a marked reduction in
IRFR and an increase in CP. There were no significant only for unfractionated leukocytes and MN cells. This
is different from what other authors have found whendifferences in the filtration variables of PMNs (Tables
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Table 1. Means and standard deviations of filtration variables of unfractionated WBC and MN cells in
normal, PPS subjects and DVT subjects.
Normal PPS DVT
Unfractionated
WBC
IRFR 0.862 s.d. 0.132 0.694 s.d. 0.156*** 0.599 s.d. 0.320**
CP (·105/ml) 2.496 s.d. 1.087 3.922 s.d. 1.482** 3.652 s.d. 1.933*
MN cells
IRFR 0.901 s.d. 0.108 0.736 s.d. 0.165*** 0.722 s.d. 0.164***
CP (·105/ml) 2.085 s.d. 1.197 3.182 s.d. 1.568* 3.496 s.d. 1.922*
* p<0.05 vs. normal patients; ** p<0.01 vs. normal patients; *** p<0.001 vs. normal patients.
Table 2. Means and standard deviations of PMN filtration variables, membrane fluidity (expressed as
TMA-DPH polarisation degree) and cytosolic Ca2+ content (expressed as ratio between Fura2-Ca2+ and
Fura2 fluorescence intensity) in normal subjects (a), in PPS subjects (b) and DVT subjects (c), at baseline
and after activation with PMA.
At baseline After 5 min After 15 min
(a)
IRFR 0.954 s.d. 0.098 0.601 s.d. 0.284*** 0.589 s.d. 0.255***
CP (·105/ml) 1.641 s.d. 0.768 8.134 s.d. 1.728*** 9.075 s.d. 0.953***
TMA-DPH 0.334 s.d. 0.026 0.339 s.d. 0.023 0.341 s.d. 0.031
Ca2+ 0.788 s.d. 0.056 0.820 s.d. 0.070 0.807 s.d. 0.074
(b)
IRFR 0.870 s.d. 0.162 0.297 s.d. 0.216*** 0.340 s.d. 0.259***
CP (·105/ml) 2.082 s.d. 0.885 7.366 s.d. 2.068*** 7.135 s.d. 1.948***
TMA-DPH 0.346 s.d. 0.020 0.353 s.d. 0.016 0.355 s.d. 0.015**
Ca2+ 0.859 s.d. 0.047§ 0.868 s.d. 0.028** 0.878 s.d. 0.025***
(c)
IRFR 0.973 s.d. 0.085 0.284 s.d. 0.226*** 0.150 s.d. 0.079***
CP (·105/ml) 1.700 s.d. 1.420 7.447 s.d. 1.916*** 7.803 s.d. 1.468***
TMA-DPH 0.339 s.d. 0.024 0.356 s.d. 0.017** 0.359 s.d. 0.027***
Ca2+ 0.858 s.d. 0.046§ 0.878 s.d. 0.035** 0.888 s.d. 0.039***
§ p<0.001 vs. normal patients; ** p<0.01 vs. baseline; *** p<0.001 vs. baseline.
Table 3. Means and standard deviations of PMN filtration variables, membrane fluidity (expressed as
TMA-DPH polarisation degree) and cytosolic Ca2+ content (expressed as ratio between Fura2-Ca2+ and
Fura2 fluorescence intensity) in normal subjects (a), in PPS subjects (b) and DVT subjects (c), at baseline
and after activation with fMLP.
At baseline After 5 min After 15 min
(a)
IRFR 0.954 s.d. 0.098 0.831 s.d. 0.158** 0.877 s.d. 0.101**
CP (·105/ml) 1.641 s.d. 0.768 4.027 s.d. 2.250** 3.538 s.d. 1.873**
TMA-DPH 0.334 s.d. 0.026 0.334 s.d. 0.025 0.338 s.d. 0.031
Ca2+ 0.788 s.d. 0.056 0.815 s.d. 0.080 0.805 s.d. 0.068
(b)
IRFR 0.870 s.d. 0.162 0.696 s.d. 0.262* 0.567 s.d. 0.260***
CP (·105/ml) 2.082 s.d. 0.885 3.574 s.d. 2.527* 4.223 s.d. 2.310*
TMA-DPH 0.346 s.d. 0.020 0.352 s.d. 0.015* 0.354 s.d. 0.016***
Ca2+ 0.859 s.d. 0.047§ 0.865 s.d. 0.026** 0.876 s.d. 0.023***
(c)
IRFR 0.973 s.d. 0.085 0.586 s.d. 0.170*** 0.455 s.d. 0.209***
CP (·105/ml) 1.700 s.d. 1.420 4.300 s.d. 2.253** 4.983 s.d. 2.249***
TMA-DPH 0.339 s.d. 0.024 0.345 s.d. 0.037 0.349 s.d. 0.029
Ca2+ 0.858 s.d. 0.046§ 0.871 s.d. 0.027 0.895 s.d. 0.089*
§ p<0.001 vs. normal patients; * p<0.05 vs. baseline; ** p<0.01 vs. baseline; *** p<0.001 vs. baseline.
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examining the leukocyte filtrability rate of patients In conclusion, the leukocyte determinants that, at
baseline, differentiated normals from subjects with PPSwith varicose veins or venous hypertension.10 These
authors, in fact, did not find any significant difference and DVT were the filtration variables of unfractionated
leukocytes and MN cells and the PMN cytosolic Ca2+in comparison with normal controls.
At baseline, no variation was noted in PMN mem- concentration. After PMN activation the trend of al-
most all PMN variables shows a different pattern ofbrane fluidity in subjects with PPS and DVT whilst in
both groups, we found an increase in PMN cytosolic behaviour between normals and the two groups of
patients. These results underline how in these clinicalCa2+ concentration. There is no previous mention in
the literature of PMN membrane fluidity and cytosolic conditions there is a functional alteration of leukocytes
whose mechanism needs further clarification.Ca2+ concentration in subjects with venous disease.
We believe that the behaviour of the PMN cytosolic
Ca2+ concentration found in these groups of patients
might be the expression of the basal activation of the
granulocytes. It is known in fact that the activation is
Referencesaccompanied by an increase of this cytosolic ion.26–29
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